Literature DB >> 4996791

Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.

P Y Paterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4996791

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.

Authors:  L Korcáková; M Titlbach; K Nouza
Journal:  Acta Diabetol Lat       Date:  1972 Nov-Dec

2.  Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

Authors:  D A Drachman; P Y Paterson; R T Schmidt; R F Spehlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

3.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Modifications in the establishment of allergic encephalomyelitis (EAE) in rats; an imporved assay for immunosuppressant drugs.

Authors:  F W Beck; M W Whitehouse
Journal:  Agents Actions       Date:  1976-07

5.  Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats.

Authors:  P Y Paterson; D G Drobish
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

6.  Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.

Authors:  F Hertz; R Deghenghi
Journal:  Agents Actions       Date:  1985-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.